Peroxisome proliferator-activated receptors as stimulants of angiogenesis in cardiovascular disease and diabetes
Cyrus v Desouza1,2, Lindsey Rentschler1, Vivian Fonseca31University of Nebraska Medical Center, 2Omaha VA Medical Center, Omaha, NE, USA; Scott & White Medical Clinic/Texas A & M College of Medicine, Temple, TX, USAAbstract: The incidence of diabetes is directly related to th...
Main Authors: | Cyrus V Desouza, Lindsey Rentschler, Vivian Fonseca |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2009-09-01
|
Series: | Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy |
Online Access: | http://www.dovepress.com/peroxisome-proliferator-activated-receptors-as-stimulants-of-angiogene-a3577 |
Similar Items
-
The role of peroxisome proliferator activated receptor agonists in Cardiovascular disease
by: Hughes, Robert Ian
Published: (2008) -
Peroxisome Proliferator-Activated Receptors in Diabetic Nephropathy
by: Shinji Kume, et al.
Published: (2008-01-01) -
Peroxisome Proliferator-Activated Receptor Agonists: Do They Increase Cardiovascular Risk?
by: Ahmad Aljada, et al.
Published: (2009-01-01) -
Impact of peroxisome proliferator-activated receptor-α on diabetic cardiomyopathy
by: Lin Wang, et al.
Published: (2021-01-01) -
Role of Peroxisome Proliferator-Activated Receptor α in Diabetic Nephropathy
by: Sungjin Chung, et al.
Published: (2011-08-01)